Zydus Lifesciences Ltd (BOM:532321)
₹ 1050.35 -8.2 (-0.77%) Market Cap: 1.06 Til Enterprise Value: 1.04 Til PE Ratio: 27.99 PB Ratio: 5.42 GF Score: 95/100

Q1 2024 Zydus Lifesciences Ltd Earnings Call Transcript

Aug 11, 2023 / 09:30AM GMT
Release Date Price: ₹651.1 (-1.06%)
Operator

Welcome to Zydus Lifesciences Limited Q1 FY '24 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ganesh Nayak, Executive Director of Zydus Lifesciences. Thank you, and over to you, sir.

Ganesh Narayan Nayak
Zydus Lifesciences Limited - COO & Executive Director

Good afternoon, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended 30th June 2023. On this call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Director's Office.

Let me now give you a broad overview of the developments during the quarter. We had a strong start to the financial year as we capitalized on the momentum built over the last several quarters and delivered robust growth across businesses. This, coupled with sustained improvement in profitability, helped us achieve the highest

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot